Topical Composition - EP2214642

The patent EP2214642 was granted to GSK Consumer Healthcare on May 3, 2017. The application was originally filed on Oct 27, 2008 under application number EP08844931A. The patent is currently recorded with a legal status of "Revoked".

EP2214642

GSK CONSUMER HEALTHCARE
Application Number
EP08844931A
Filing Date
Oct 27, 2008
Status
Revoked
Mar 5, 2021
Grant Date
May 3, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KERN PHARMAFeb 2, 2018LEDERER & KELLERADMISSIBLE
KERN PHARMAFeb 2, 2018LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE
PRUFER & PARTNER MBBFeb 2, 2018MAIWALDADMISSIBLE

Patent Citations (22) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP0879597
INTERNATIONAL-SEARCH-REPORTEP1457202
INTERNATIONAL-SEARCH-REPORTUS4917886
INTERNATIONAL-SEARCH-REPORTWO0051575
INTERNATIONAL-SEARCH-REPORTWO2004030665
OPPOSITIONCZ290752
OPPOSITIONEP1457202
OPPOSITIONJPH0912452
OPPOSITIONUS4407824
OPPOSITIONUS4917886
OPPOSITIONWO0051575
OPPOSITIONWO02078648
OPPOSITIONWO0211700
OPPOSITIONWO0217905
OPPOSITIONWO2004017998
OPPOSITIONWO2004030665
OPPOSITIONWO9742944
OTHEREP1457202
OTHERUS2005239894
OTHERUS4917886
OTHERWO0051575
OTHERWO2004030665

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "05 540 Voltaren Emulgel", Rote Liste 2007, (20070000), XP055463163-
OPPOSITION- Anonymous, Medicines Compendium 2005, Datapharm Communications Ltd.,, (20050000), pages 2201 - 2202, XP055461644-
OPPOSITION- Babu et al, Babu et al, SMITH et al., Percutaneous Penetration Enhancers, 2nd ed., (20060000), pages 137 - 138, 153-154, XP055461626-
OPPOSITION- CHARLES FOX, "Skin Care: An Overview and Update on the State of the Art and Science", Cosmetics and Toiletries, (19840300), vol. 99, pages 41 - 54, XP055461617-
OPPOSITION- "Disorders of Connective Tissue, Bone and Joints", Chris J. van BOXTEL et al., Drug Benefits and Risks - International Textbook of Clinical Pharmacology, John Wiley & Sons, Ltd., (20010000), page 577, XP055461632-
OPPOSITION- FANG et al., "Influence of Electrical and Chemical Factors on Transdermal Iontophoretic Delivery of Three Diclofenac Salts", Biol. Pharm. Bull., (20010000), vol. 24, no. 4, pages 390 - 394, XP055463189-
OPPOSITION- KHALIL et al., "Aqueous Solubility of Diclofenac Diethylamine in the Presence of Pharmaceutical Additives: A Comparative Study with Diclofenac Sodium", Drug Dev. Ind. Pharm., (20000000), vol. 26, no. 4, pages 375 - 381, XP055463187-
OPPOSITION- Miranda Hitti, "FDA Oks Voltaren Gel for Osteoarthritis", WebMD Archives, (20071023), pages 1 - 2, URL: https://www.webmd.com/osteoarthritis/news/20071023/fda-oks-voltaren-gel-for-osteoarthritis?print=true, XP055461659-
OPPOSITION- R.J. Babu Et Al.,, "Chapter 12- Fatty Alcohols and Fatty Acids", R.J. Babu Et Al.,, Eric W. SMITH , Howard I. Maibach, Percutaneous Penetration Enhancers, Second Edition, Taylor and Francis, New York,, (20060000), pages 137, 138, 153 - 154, XP055461626-
OPPOSITION- R. VOIGT, Lehrbuch der Pharmazeutischen Technologie, 6. auflage, (19870000), pages 667 - 669, XP055463181-
OPPOSITION- AGNIHOTRI et al., "Electrically Modulated Transport of Diclofenac Salts Through Hydrogels of Sodium Alginate , Carbopol, and Their Blend Polymers", J. Appl. Sci., (20050000), vol. 96, no. 2, pages 301 - 311, XP055463190
OPPOSITION- MINGHETTI et al., "Ex Vivo Study of Transdermal Permeation of Four Diclofenac Salts from Different Vehicles", J. Pharm. Sci., (20070400), vol. 96, no. 4, pages 814 - 823, XP002503203

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents